Nautilus Biotechnology, Inc. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
Nautilus Biotechnology, Inc. (NAUT) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$240.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-07-28
- Nautilus Biotechnology, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-06-30 was -$240.00K.
- Nautilus Biotechnology, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was -$334.00K, a 353.03% decline year-over-year.
- Nautilus Biotechnology, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-12-31 was $43.00K.
- Nautilus Biotechnology, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-09-30 was $123.00K, a 90.37% decline year-over-year.
- Nautilus Biotechnology, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was $186.00K, a 40.38% decline from fiscal 2024.
- Nautilus Biotechnology, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was $312.00K, a 80.49% decline from fiscal 2023.
- Nautilus Biotechnology, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was $1.60M.
- Nautilus Biotechnology, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2022 was -$1.67M.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$240.00K 10-Q · filed 2026-07-28 | -$574.00K 10-Q · filed 2026-07-28 | -$531.00K derived: sum of 3 quarters · filed 2026-07-28 | -$408.00K derived: sum of 4 quarters · filed 2026-07-28 |
| 2026-03-31 | -$334.00K 10-Q · filed 2026-04-28 | -$291.00K derived: sum of 2 quarters · filed 2026-04-28 | -$168.00K derived: sum of 3 quarters · filed 2026-04-28 | -$280.00K derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-12-31 | $43.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $166.00K derived: sum of 2 quarters · filed 2026-02-26 | $54.00K derived: sum of 3 quarters · filed 2026-07-28 | $186.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | $123.00K 10-Q · filed 2025-10-28 | $11.00K derived: sum of 2 quarters · filed 2026-07-28 | $143.00K 10-Q · filed 2025-10-28 | -$531.00K derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-06-30 | -$112.00K 10-Q · filed 2026-07-28 | $20.00K 10-Q · filed 2026-07-28 | -$654.00K derived: sum of 3 quarters · filed 2026-07-28 | $623.00K derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-03-31 | $132.00K 10-Q · filed 2026-04-28 | -$542.00K derived: sum of 2 quarters · filed 2026-04-28 | $735.00K derived: sum of 3 quarters · filed 2026-04-28 | $934.00K derived: sum of 4 quarters · filed 2026-04-28 |
| 2024-12-31 | -$674.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $603.00K derived: sum of 2 quarters · filed 2026-02-26 | $802.00K derived: sum of 3 quarters · filed 2026-02-26 | $312.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $1.28M 10-Q · filed 2025-10-28 | $1.48M derived: sum of 2 quarters · filed 2025-10-28 | $986.00K 10-Q · filed 2025-10-28 | $2.76M derived: sum of 4 quarters · filed 2025-10-28 |
| 2024-06-30 | $199.00K 10-Q · filed 2025-07-31 | -$291.00K 10-Q · filed 2025-07-31 | $1.49M derived: sum of 3 quarters · filed 2025-07-31 | $1.84M derived: sum of 4 quarters · filed 2025-07-31 |
| 2024-03-31 | -$490.00K 10-Q · filed 2025-04-29 | $1.29M derived: sum of 2 quarters · filed 2025-04-29 | $1.64M derived: sum of 3 quarters · filed 2025-04-29 | $214.00K derived: sum of 4 quarters · filed 2025-04-29 |
| 2023-12-31 | $1.78M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $2.13M derived: sum of 2 quarters · filed 2025-02-27 | $704.00K derived: sum of 3 quarters · filed 2025-02-27 | $1.60M 10-K · filed 2025-02-27 |
| 2023-09-30 | $356.00K 10-Q · filed 2024-10-29 | -$1.07M derived: sum of 2 quarters · filed 2024-10-29 | -$179.00K 10-Q · filed 2024-10-29 | -$152.00K derived: sum of 4 quarters · filed 2024-10-29 |
| 2023-06-30 | -$1.43M 10-Q · filed 2024-07-30 | -$535.00K 10-Q · filed 2024-07-30 | -$508.00K derived: sum of 3 quarters · filed 2024-07-30 | -$1.62M derived: sum of 4 quarters · filed 2024-07-30 |
| 2023-03-31 | $895.00K 10-Q · filed 2024-04-30 | $922.00K derived: sum of 2 quarters · filed 2024-04-30 | -$191.00K derived: sum of 3 quarters · filed 2024-04-30 | -$405.00K derived: sum of 4 quarters · filed 2024-04-30 |
| 2022-12-31 | $27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$1.09M derived: sum of 2 quarters · filed 2024-02-28 | -$1.30M derived: sum of 3 quarters · filed 2024-02-28 | -$1.67M 10-K · filed 2024-02-28 |
| 2022-09-30 | -$1.11M 10-Q · filed 2023-10-31 | -$1.33M derived: sum of 2 quarters · filed 2023-10-31 | -$1.70M 10-Q · filed 2023-10-31 | -$1.87M derived: sum of 4 quarters · filed 2023-10-31 |
| 2022-06-30 | -$214.00K 10-Q · filed 2023-08-02 | -$584.00K 10-Q · filed 2023-08-02 | -$759.00K derived: sum of 3 quarters · filed 2023-08-02 | -$758.00K derived: sum of 4 quarters · filed 2023-08-02 |
| 2022-03-31 | -$370.00K 10-Q · filed 2023-05-02 | -$545.00K derived: sum of 2 quarters · filed 2023-05-02 | -$544.00K derived: sum of 3 quarters · filed 2023-05-02 | -$556.00K derived: sum of 4 quarters · filed 2023-05-02 |
| 2021-12-31 | -$175.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | -$174.00K derived: sum of 2 quarters · filed 2023-02-23 | -$186.00K derived: sum of 3 quarters · filed 2023-02-23 | -$187.00K 10-K · filed 2023-02-23 |
| 2021-09-30 | $1.00K 10-Q · filed 2022-11-01 | -$11.00K derived: sum of 2 quarters · filed 2022-11-01 | -$12.00K 10-Q · filed 2022-11-01 | -$25.00K derived: sum of 4 quarters · filed 2022-11-01 |
| 2021-06-30 | -$12.00K 10-Q · filed 2022-08-02 | -$13.00K 10-Q · filed 2022-08-02 | -$26.00K derived: sum of 3 quarters · filed 2022-08-02 | -$26.00K derived: sum of 4 quarters · filed 2022-08-02 |
| 2021-03-31 | -$1.00K 10-Q · filed 2022-05-03 | -$14.00K derived: sum of 2 quarters · filed 2022-05-03 | -$14.00K derived: sum of 3 quarters · filed 2022-05-03 | -$39.00K derived: sum of 4 quarters · filed 2022-05-03 |
| 2020-12-31 | -$13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$13.00K derived: sum of 2 quarters · filed 2022-02-24 | -$38.00K derived: sum of 3 quarters · filed 2022-02-24 | -$4.00K 10-K · filed 2022-02-24 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-02 | -$25.00K derived: sum of 2 quarters · filed 2021-11-02 | $9.00K 10-Q · filed 2021-11-02 | |
| 2020-06-30 | -$25.00K 10-Q · filed 2021-08-10 | $9.00K 10-Q · filed 2021-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |